ZBH - Zimmer Biomet Holdings, Inc.

NYSE - NYSE Delayed Price. Currency in USD
114.52
+0.56 (+0.49%)
At close: 4:01PM EDT
Stock chart is not supported by your current browser
Trade prices are not sourced from all markets
Previous Close113.96
Open114.08
Bid110.00 x 900
Ask114.91 x 1100
Day's Range114.00 - 115.06
52 Week Range96.99 - 134.55
Volume486,381
Avg. Volume1,208,062
Market Cap23.453B
Beta (3Y Monthly)1.36
PE Ratio (TTM)N/A
EPS (TTM)-1.51
Earnings DateJul 25, 2019 - Jul 29, 2019
Forward Dividend & Yield0.96 (0.78%)
Ex-Dividend Date2019-03-28
1y Target Est135.19
  • Investors are overly pessimistic, now is the time buy: Investment strategist
    CNBC Videoslast month

    Investors are overly pessimistic, now is the time buy: Investment strategist

    Jeff Krumpelman, chief investment strategist and head of equities at Mariner Wealth Advisors, and Kenny Polcari, managing principal at Butcher Joseph Asset Management, join CNBC's "The Exchange" to discuss mid-day markets and the stocks they're watching.

  • MoneyShow16 days ago

    Buckingham's Bets- Two Values in Healthcare

    First quarter corporate report cards generally have been good, with 75% or so of S&P; 500 companies beating earnings estimates, observes John Buckingham, value investing expert and editor of The Prudent Speculator.

  • GuruFocus.com17 days ago

    Jeff Auxier Comments on Zimmer Biomet

    Guru stock highlight

  • GuruFocus.com18 days ago

    Jeff Auxier's 1st Quarter Auxier Focus Fund Shareholder Letter

    The Fed made a material reversal at year-end and lower interest rates have fueled gains for both stocks and bonds. Unprecedented technological innovation is driving impressive productivity gains which has helped to keep inflation in check. Where socialism grows so does inflation and stagnation.

  • Markit19 days ago

    See what the IHS Markit Score report has to say about Zimmer Biomet Holdings Inc.

    Zimmer Biomet Holdings Inc NYSE:ZBHView full report here! Summary * ETFs holding this stock are seeing positive inflows but are weakening * Bearish sentiment is low * Economic output in this company's sector is expanding Bearish sentimentShort interest | PositiveShort interest is extremely low for ZBH with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting ZBH. Money flowETF/Index ownership | NegativeETF activity is negative and may be weakening. The net inflows of $1.67 billion over the last one-month into ETFs that hold ZBH are among the lowest of the last year and appear to be slowing. Economic sentimentPMI by IHS Markit | PositiveAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is strong relative to the trend shown over the past year, and is accelerating. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • Thomson Reuters StreetEvents26 days ago

    Edited Transcript of ZBH earnings conference call or presentation 26-Apr-19 12:30pm GMT

    Q1 2019 Zimmer Biomet Holdings Inc Earnings Call

  • Zimmer Biomet Holdings (ZBH) Q1 2019 Earnings Call Transcript
    Motley Fool29 days ago

    Zimmer Biomet Holdings (ZBH) Q1 2019 Earnings Call Transcript

    ZBH earnings call for the period ending March 31, 2019.

  • Zimmer Biomet's (ZBH) Q1 Earnings, Revenues Beat Estimates
    Zacks29 days ago

    Zimmer Biomet's (ZBH) Q1 Earnings, Revenues Beat Estimates

    While sales in Americas remains dull, Zimmer Biomet (ZBH) is witnessing strength in the Asia Pacific and EMEA regions.

  • Zimmer Biomet Holdings Sales and Earnings Slip in Q1
    Motley Fool29 days ago

    Zimmer Biomet Holdings Sales and Earnings Slip in Q1

    The musculoskeletal healthcare company continues to try to turn things around, with limited success in the first quarter.

  • Associated Presslast month

    Zimmer: 1Q Earnings Snapshot

    On a per-share basis, the Warsaw, Indiana-based company said it had net income of $1.20. Earnings, adjusted for one-time gains and costs, came to $1.87 per share. The results surpassed Wall Street expectations. ...

  • PR Newswirelast month

    Zimmer Biomet Announces First Quarter 2019 Financial Results

    - Net sales of $1.976 billion for the first quarter represent a decrease of 2.1% from the prior year period, an increase of 0.7% on a constant currency basis - Diluted earnings per share for the first ...

  • Will Pricing Pressure Hurt Zimmer Biomet (ZBH) Q1 Earnings?
    Zackslast month

    Will Pricing Pressure Hurt Zimmer Biomet (ZBH) Q1 Earnings?

    With Zimmer Biomet (ZBH) focusing solely on this restructuring initiative, chances are slim for the company to post promising growth performances across its operating segments.

  • ACCESSWIRElast month

    Update in Lawsuit for Investors in shares of Zimmer Biomet Holdings Inc (NYSE: ZBH) announced by Shareholders Foundation

    SAN DIEGO, CA / ACCESSWIRE / April 24, 2019 / The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in shares of Zimmer Biomet Holdings Inc (NYSE: ZBH). Investors ...

  • PR Newswirelast month

    Zimmer Biomet to Present at Bank of America Merrill Lynch Healthcare Conference

    WARSAW, Ind. , April 23, 2019 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, will participate in the Bank of America Merrill Lynch Healthcare ...

  • Earnings Preview: Zimmer Biomet (ZBH) Q1 Earnings Expected to Decline
    Zackslast month

    Earnings Preview: Zimmer Biomet (ZBH) Q1 Earnings Expected to Decline

    Zimmer (ZBH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • T Rowe Price Equity Income Fund Buys 6 Stocks in 1st Quarter
    GuruFocus.comlast month

    T Rowe Price Equity Income Fund Buys 6 Stocks in 1st Quarter

    Top buys include Conagra and Fox spinoff

  • Thomson Reuters StreetEventslast month

    Edited Transcript of ZBH earnings conference call or presentation 1-Feb-19 1:30pm GMT

    Q4 2018 Zimmer Biomet Holdings Inc Earnings Call

  • Were Hedge Funds Right About Zimmer Biomet Holdings Inc (ZBH)?
    Insider Monkey2 months ago

    Were Hedge Funds Right About Zimmer Biomet Holdings Inc (ZBH)?

    Zimmer Biomet Holdings Inc (NYSE:ZBH) investors should be aware of a decrease in hedge fund sentiment in recent months. Zimmer Biomet Holdings Inc (ZBH) was in 36 hedge funds' portfolios at the end of the fourth quarter of 2018. There were 40 hedge funds in our database with ZBH positions at the end of the previous […]

  • Zimmer Biomet's FDA 510(k) Nod Widens Robotic Offerings
    Zacks2 months ago

    Zimmer Biomet's FDA 510(k) Nod Widens Robotic Offerings

    With the FDA nod, Zimmer Biomet (ZBH) attains the status of being the first company to boast the 510(k) clearance for Brain, Spine and Knee offerings on a single robotic platform globally.

  • PR Newswire2 months ago

    Zimmer Biomet Receives FDA Clearance of ROSA® ONE Spine System for Robotically-Assisted Surgeries

    The platform features 3D intraoperative planning software in addition to a navigation suite of technologies designed to improve implant as well as instrument placement accuracy and predictability. "ROSA ONE Spine functions as a dual robotics and navigation technology solution for minimally invasive and complex thoracolumbar spine procedures," said Aure Bruneau, Zimmer Biomet's Group President, Spine, CMF and Thoracic and Surgery Assisting Technology.

  • PR Newswire2 months ago

    Zimmer Biomet Holdings Announces Audio Webcast and Conference Call of First Quarter 2019 Results

    WARSAW, Ind. , March 22, 2019 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its first quarter sales and earnings conference call will be broadcast over the Internet on ...

  • Zimmer Biomet Solid on Global Prospects Despite Price Pressure
    Zacks2 months ago

    Zimmer Biomet Solid on Global Prospects Despite Price Pressure

    Zimmer Biomet (ZBH) has been working to strengthen foothold in emerging markets. However, the company has been facing continued pricing pressure.

  • RTI Surgical Buys Paradigm Spine, Adds Coflex to Portfolio
    Zacks2 months ago

    RTI Surgical Buys Paradigm Spine, Adds Coflex to Portfolio

    RTI Surgical's (RTIX) acquisition of Paradigm Spine aligns with the former's goal of expanding its spine portfolio.

  • PR Newswire2 months ago

    Zimmer Biomet Exhibits Unique Ecosystem of Solutions at AAOS 2019

    WARSAW, Ind., March 12, 2019 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced it will be showcasing its latest commercial offerings and previewing its next generation of technological innovations at the American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting, March 13-15 in Las Vegas, Nevada. "In addition to our ongoing commitment to advancing our traditional implant offering, Zimmer Biomet is transforming the patient journey through an ecosystem of differentiated solutions to provide more personalized care for the patient," said Bryan C. Hanson, President and CEO of Zimmer Biomet.